Efficacy of combined antiviral therapy with lamivudine and tenofovir in a liver transplanted girl with de novo hepatitis B virus infection

M. Tufano, D. Liccardo, S. Riva, M. Candusso, G. Torre, R. Iorio

Research output: Contribution to journalArticlepeer-review

Abstract

The management of de novo hepatitis B (HBV) infection in children after liver transplantation is not well defined. Because this infection may induce severe liver disease in the graft liver, an efficient antiviral therapy is desirable. Here, we describe the favorable viral outcome observed in a liver transplanted girl with de novo HBV infection following combination therapy with lamivudine and tenofovir.

Original languageEnglish
JournalTransplant Infectious Disease
Volume15
Issue number2
DOIs
Publication statusPublished - Apr 2013

Keywords

  • Children
  • Combined antiviral therapy
  • de novo HBV infection
  • Hepatitis B
  • Lamivudine
  • Liver transplantation
  • Tenofovir

ASJC Scopus subject areas

  • Transplantation
  • Infectious Diseases

Fingerprint Dive into the research topics of 'Efficacy of combined antiviral therapy with lamivudine and tenofovir in a liver transplanted girl with de novo hepatitis B virus infection'. Together they form a unique fingerprint.

Cite this